Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranexa for palpitations in ischemic heart disease
NCT01495520Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ranolazine in ischemic heart disease (IHD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
ranolazine
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT01495520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495520.